Iron and magnesium exchange via the low affinity iron transporter in rabbit erythroid cells—exchange rates and the action of valinomycin, diethylstilbestrol and protein kinase inhibitors  by Savigni, Donna L. & Morgan, Evan H.
www.bba-direct.com
Biochimica et Biophysica Acta 1616 (2003) 156–164Iron and magnesium exchange via the low affinity iron transporter in
rabbit erythroid cells—exchange rates and the action of valinomycin,
diethylstilbestrol and protein kinase inhibitors
Donna L. Savigni, Evan H. Morgan*
Department of Physiology, School of Biomedical and Chemical Sciences, The University of Western Australia, 35 Stirling Highway,
Crawley, Western Australia 6009, AustraliaReceived 2 June 2003; received in revised form 31 July 2003; accepted 14 August 2003Abstract
Evidence was presented previously that rabbit erythroid cells possess a low-affinity Fe2 + transport system which operates via the Na+/
Mg2 + antiport [Biochim. Biophys. Acta 1282 (1996) 163]. This was investigated further by measurements of Mg2 + efflux as well as Fe2 +
uptake by the cells and by examining the inhibitory effects of valinomycin, diethylstilbestrol (DES) and protein kinase inhibitors. Mg2 +
efflux and Fe2 + uptake were measured using rabbit reticulocytes and mature erythrocytes incubated in isotonic KCl or NaCl solutions. Both
processes were slower in mature cells than reticulocytes. Mg2 + efflux into KCl solution was much lower than into NaCl solution but was
stimulated by addition of Fe2 + to the solution. The rate of Fe2 +-stimulated Mg2 + efflux closely followed that of Fe2 + uptake in a one-to-one
molar ratio. Valinomycin, DES and the protein kinase inhibitors all inhibited Fe2 + uptake from KCl solution. Valinomycin also inhibited
Fe2 +-stimulated Mg2 + efflux into KCl solution but markedly stimulated the efflux into NaCl. Maximal inhibition of Fe2 + uptake from KCl
solution required the presence of K+, Rb+ or Cs+ ions with which valinomycin forms strong complexes. The results could not be explained on
the basis of changes in cell membrane potential or cell volume. By contrast, the increase in Mg2 + efflux into NaCl solution produced by
valinomycin was accompanied by cell shrinkage and production of a more negative membrane potential, either of which may be responsible
for the effect. The inhibition produced by the protein kinase inhibitors indicate that phosphorylation of the transporter or an associated protein
by protein tyrosine kinase is probably required to activate the transporter.
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1. Introduction across the endosomal membrane after receptor-mediatedFerrous iron (Fe2 +) is transported into rabbit and rat
reticulocytes by at least two distinct mechanisms [1–5].
One, high-affinity transport, is present in reticulocytes but
disappears as the cells mature into erythrocytes [2,4,6,7]. It
has properties, including impaired function in reticulocytes
from homozygous Belgrade rats [2,4], which show that it is
mediated by divalent metal transporter 1 (DMT1) [8]. This
is probably the mechanism by which iron is transported0005-2736/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2003.08.004
Abbreviations: DES, diethylstilbestrol; MCHC, mean corpuscular
hemoglobin concentration; PCV, packed cell volume; Vm, transmembrane
potential difference
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E-mail address: ehmorgan@cyllene.uwa.edu.au (E.H. Morgan).uptake of transferrin-bound iron, the normal source of iron
for developing erythroid cells [9,10].
The second transport process which has a lower affinity
but higher capacity for iron transport [2,4,5] is less well
defined. It persists in mature red blood cells but at a lower
level of activity than in reticulocytes and is not impaired in
cells from Belgrade rats [2,4]. The iron taken up is
incorporated into heme but less efficiently than iron taken
up from transferrin [2,5]. There is evidence that iron
transport by this process is mediated by the Na+/Mg2 +
antiport [11]. The iron uptake is inhibited by Na+ and
stimulated by K+ in the extracellular fluid [1,2]. The results
suggest that, in Na+-free solutions such as isotonic KCl,
Fe2 + can substitute for extracellular Na+ and be transported
into the cell in exchange for Mg2 + [11]. Confirmation of
this requires measurement of the rates of movement of Fe
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are known to affect the rate of iron transport such as
changes in iron concentration and the presence of inhibitors
of iron transport. Two of the most potent inhibitors are
valinomycin and diethylstilbestrol (DES) [3–5]. Moreover,
there is evidence that protein phosphorylation is required
for function of the Na+/Mg2 + antiport [12]. Is it also
required for Fe uptake?
The aim of this investigation was to investigate the
mechanism of low-affinity iron transport into reticulocytes
by comparing the rates of Fe2 + uptake and Mg2 + efflux and
by studying the actions of valinomycin, DES and protein
kinase inhibitors on Fe2 + uptake. The experiments were
performed with freshly obtained rabbit reticulocytes and
mature erythrocytes. In most cases, they were incubated in
isotonic KCl solution, pH 7.0, conditions which produce
maximal Fe2 + uptake [2]. The results showed that addition
of Fe2 + to the KCl solution stimulated Mg2 + efflux from the
cells at a rate proportional to that of Fe2 + uptake. Inhibitors
of Fe uptake from KCl solution also inhibited Mg efflux.
However, in NaCl solution, they had little effect on Mg
efflux and, in the case of valinomycin, there was stimulation
of efflux.2. Materials and methods
2.1. Materials
Radioactive iron, 59Fe (FeCl3) was purchased from
Dupont (Sydney, NSW, Australia). The biochemical
reagents were from Sigma Chemical Company (St. Louis,
MO, USA). Reticulocyte-rich blood was obtained from
rabbits with phenylhydrazine-induced hemolytic anemia,
4–6 days after the last injection of phenylhydrazine [13].
The cells were washed three times in 0.155 M NaCl and
then centrifuged at a packed cell volume (PCV) of approx-
imately 0.7 at 4 jC for 30 min at 2500 g. The top one-
quarter of the cell layer was removed and washed once more
in the final incubation solution, 0.155 M KCl, 0.155 M
NaCl or 0.27 M sucrose. The cells were then suspended at a
PCVof 0.3–0.4 in the same solution. The buffy coat (white
cells and platelets) was removed after each centrifugation
before resuspending the cells in the next washing solution.
The reticulocyte count of the final cell suspensions varied
from 33% to 83%. To differentiate them from suspensions
containing virtually only mature erythrocytes (see below),
the cells of the reticulocyte-rich cell suspensions will be
referred to as reticulocytes even though they did contain
some mature cells. The Mg2 + content of the cells was
6.05F 0.35 mmol/l cells (n = 5).
Mature erythrocytes, obtained from normal rabbits not
treated with phenylhydrazine, were washed in the same
way as reticulocytes except that the bottom one-quarter
of the cells was taken after the 30-min centrifugation.
The reticulocyte count of these cells varied from 1% to3% and the Mg2 + content was 4.28F 0.16 mmol/l cells
(n = 4).
2.2. Measurement of iron uptake and magnesium efflux
Iron uptake was determined by incubating 50 Al samples
of the cell suspensions in 2.0 ml Hepes-buffered (pH 7.0)
isotonic KCl solution (290 mOsm/kg) or NaCl solution (pH
7.4) at 37 jC for 15 min in the presence of 59Fe-labelled
Fe2 +, as in earlier work [2,4]. As shown in these earlier
studies, incubation in KCl, pH 7.0 provides optimal con-
ditions for iron uptake by the low-affinity uptake process
but is strongly inhibitory of high-affinity Fe2 + uptake. It
was also shown that iron uptake by the cells is linear for at
least 30 min. Hence, the results obtained with a 15-min
incubation period can be used to calculate the rate of iron
uptake. After incubation, the cells were washed 3 times with
ice-cold 0.155 M NaCl, followed by hemolysis in 15 mM
Hepes (pH7.4) and centrifugation to separate cytosolic and
membrane fractions of the cells [1,3]. These fractions were
then counted for radioactivity in a g-scintillation counter
(1282 Compugamma, LKB Wallac, Sweden). The iron
concentration used in most experiments was 20 AM but in
some experiments, the concentration was varied as detailed
below. Because this study is concerned with Fe2 + transport
through the cell membrane, only iron uptake to the cytosolic
fraction of the cells will be reported. It represented 64–79%
of the total uptake. The remainder was present in the
membrane fraction. The amount of iron incorporated into
this fraction increased as the iron concentration in the
incubation medium was raised but in no experiment did it
exceed 36% of total uptake.
Mg2 + efflux was measured by incubating 50 Al samples
of the cell suspensions in 2.0 ml Hepes-buffered KCl as for
Fe2 + uptake or in 2.0 ml Hepes-buffered NaCl. A sample
was taken at zero time, then incubation was commenced and
a further four or five samples taken during the next 45 to 60
min. The samples were chilled in an ice bath for 2 min and
then centrifuged at 4 jC for 8 min at 1250 g. An aliquot of
the supernatant solution was removed and the Mg2 + con-
centration measured by atomic absorption spectroscopy
using a Varian Spectrophotometer AA-640Z instrument
(Varian Australia Pty Ltd, Mulgrave, Victoria, Australia).
The rate of Mg2 + efflux from the cells was determined by
linear regression analysis of the results for Mg2 + concen-
tration in the incubation solution. The Mg2 + content of the
original cell suspension was determined by mixing 25 Al of
cell suspension with 5.0 ml 10% (w/v) trichloroacetic acid
followed by centrifugation at 4 jC for 15 min at 1250 g
and measurement of Mg in the supernatant solution.
When inhibitors were used, the cells were preincubated
with the reagents for 10 min at room temperature before
Fe2 + uptake or Mg2 + efflux were measured. In most experi-
ments, iron uptake was measured only with KCl solution,
not NaCl, because NaCl markedly inhibits Fe2 + uptake (see
Refs. [2–4] and Fig. 3, below).
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The reticulocyte count was determined by staining blood
cells with new methylene blue. Hemoglobin was determined
by mixing 20 Al samples of the cell suspensions with 4 ml
0.04 % (v/v) NH4OH solution and measurement of the
absorbance at 541 nm. The assay was calibrated using
standards of known hemoglobin concentration provided by
the New South Wales Red Cross Blood Transfusion Service
(Sydney, NSW, Australia). PCV was measured by the
microhematocrit method. Osmolality was measured by
freezing point depression using a Fiske One-Ten Osmome-
ter (Fiske, Needham Heights, MA, USA). Transmembrane
potential differences were determined by the method of
Macey et al. [14].
The results are presented as meansF S.E. of three to five
experiments. Significance of difference between means
(P < 0.05) was assessed using Student’s t test.
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erythrocytes (B). The cells were incubated in isotonic KCl without or with
the addition of 20, 50 or 100 AM Fe2 + and in NaCl without addition of
Fe2 + for Mg2 + efflux, or in KCl plus 20, 50 or 100 AM Fe2 + for the
measurement of Fe2 + uptake. Each value is the meanF S.E. of four
measurements.3. Results
3.1. Magnesium efflux and iron uptake
The rate of Mg2 + efflux from reticulocytes into KCl
solution alone was low but increased markedly when Fe2 +
was added to the KCl. The efflux was greater when the
Fe2 + concentration was 50 or 100 AM than when it was
20 AM, and with 50 or 100 AM Fe2 +, the rate was as
high as that found with incubation in NaCl solution
(Fig. 1A).
Fe2 + uptake from KCl increased as the Fe2 + concentra-
tion was raised (Fig. 1A), the mean values at each concen-
tration level being approximately equal to the rate of iron-
dependent Mg2 + efflux calculated by subtracting the values
for efflux into KCl alone from those for efflux into KCl
containing 20, 50 or 100 AM Fe2 +. When the individual
values for Fe2 + uptake and iron-dependent Mg2 + efflux
were compared (Fig. 2), there was a highly significant linear
correlation (P < 0.0001). The slope of the regression line
(0.813) did not differ significantly from 1.0.
Fe2 + uptake and Mg2 + efflux were also measured in
three experiments with mature erythrocytes. As with retic-
ulocytes, Fe2 + and Mg2 + exchange increased as the Fe2 +
concentration was raised but the rates were lower than in
reticulocytes (Fig. 1B).
Fe2 + uptake and Mg2 + efflux from reticulocytes incu-
bated in KCl solution containing 20 AM Fe2 + were both
markedly inhibited by valinomycin (0.5 AM), DES (20 AM),
imipramine (20 AM) and amiloride (500 AM) (Fig. 3). Iron
uptake from NaCl was extremely low and was not affected
significantly by the inhibitors. Mg2 + efflux into NaCl
solution was significantly inhibited by DES although the
degree of inhibition was less than that observed with KCl
plus Fe2 +. However, imipramine and amiloride had no
significant effect and efflux was greatly enhanced by vali-nomycin when the incubations were performed in NaCl
(Fig. 3).
3.2. Action of valinomycin on iron uptake
Iron uptake from KCl solution was inhibited by valino-
mycin in a dose-dependent manner, maximum inhibition of
more than 90% occurring at concentrations of 0.5–1.0 AM
(Fig. 4). Valinomycin is an ionophore with high selectivity
for K+ [15,16]. Another ionophore with similar ion selec-
tivity, but with lower affinity for K+, is nonactin [16,17].
This reagent had no effect on Fe2 + uptake when used in the
same concentration range as valinomycin (Fig. 4) and even
at concentrations of 2.5, 5 and 10 AM continued to have no
effect (results not shown). However, at 1 AM concentration,
it did produce similar changes to the transmembrane
potential difference as valinomycin (see below). It was
observed previously that iron uptake from solutions of
RbCl and CsCl was as efficient as from KCl but was lower
when the KCl was replaced by LiCl [2]. Valinomycin was
Fig. 4. Action of valinomycin and nonactin on Fe2 + uptake by rabbit
reticulocytes. The results are presented as the percentage of the control
value obtained in the absence of the reagents. Each value is the meanF S.E.
from three experiments.
Fig. 2. Relationship between the rates of Fe2 + uptake and iron-dependent
Mg2 + efflux in rabbit reticulocytes incubated in KCl solution containing 20,
50 or 100 AM Fe2 + solution.
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dependent manner similar to that observed with KCl but
had much less effect on uptake from LiCl and choline
chloride solutions, especially at concentrations up to 0.3
AM (Fig. 5).
The effect of valinomycin was also influenced by the
KCl concentration (Fig. 6). In cells incubated with 20 AM
Fe2 + in isotonic sucrose solution, valinomycin stimulated
iron uptake, as had been observed earlier with lower con-
centrations of iron [18]. When the sucrose was replaced
progressively with increasing proportions of isotonic KCl,Fig. 3. Effects of inhibitors (0.5 AM valinomycin (V), 20 AM
diethylstilbestrol (D), 20 AM imipramine (I) and 500 AM amiloride (A))
on the rates of Mg2 + efflux in rabbit reticulocytes incubated in isotonic
NaCl solution or KCl solution containing 20 AM Fe2 + and of Fe2 + uptake
from NaCl or KCl containing 20 AM Fe2 +. Also shown are the results
obtained in the absence of the inhibitors (C). Each value is the meanF S.E.
of four measurements. *Significant differences ( P < 0.05) from correspond-
ing control (C) value.iron uptake in the absence of valinomycin increased to
maximum values at about 100 AM KCl, while valinomycin
inhibited uptake to a degree which increased as the KCl
concentration was raised (Fig. 6).
Valinomycin increases the membrane conductance of K+
and changes the membrane potential (Vm) of erythrocytes
and reticulocytes from one dependent on the [Cli
]/[Clo
]
distribution ratio to one dependent on K+ [18]. It therefore
has different effects on Vm depending on whether the cells
are suspended in KCl, NaCl or sucrose solutions. To see
whether changes in Vm could be responsible for the ob-
served effects of valinomycin on Fe2 + and Mg2 + transport,Fig. 5. Valinomycin-induced inhibition of Fe2 + uptake by rabbit
reticulocytes incubated in isotonic media, pH 7.0, with different cation
compositions. The cells were incubated with 20 AM Fe2 + and with varying
concentrations of valinomycin in the media shown in the figure. The results
are the meansF S.E. of three or four experiments with each salt.
Fig. 6. Effect of KCl concentration of Fe2 + uptake by rabbit reticulocytes in
the absence (control) or presence of valinomycin (0.5 AM). The KCl
concentration was changed by mixing isotonic KCl with isotonic sucrose, in
varying proportions. The Fe2 + concentration in the incubation media was
20 AM. The values are the meansF S.E. of three experiments.
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sucrose which was progressively changed by replacement
with increasing quantities of isotonic KCl or NaCl at pH 7.0,
with or without the addition of valinomycin (0.5 AM). In the
absence of valinomycin, the Vm fell from a high positive
value (inside versus outside) in sucrose solution to lower
values as the KCl or NaCl replaced the sucrose, reaching
about  10 mV in 140 mM KCl or NaCl. In the presence of
valinomycin, the mean Vm was  55 mV in sucrose solution
and rose to near zero as the KCl concentration was raised
but showed little change with increasing NaCl concentration
(Fig. 7). Similar changes in Vm were found in two experi-Fig. 7. Transmembrane potential difference, Vm (inside versus outside of
cell), in rabbit reticulocytes incubated in isotonic KCl or NaCl mixed with
isotonic sucrose in varying proportions to give the indicated salt
concentrations. The incubations were performed without (control) or with
0.5 AM valinomycin. The values are the meansF S.E. of three experiments.ments using nonactin (1 AM) instead of valinomycin (results
not shown).
The mechanism of interaction between valinomycin and
Fe2 + uptake was further investigated by determining the
effects of varying concentrations of valinomycin on iron
uptake from KCl solutions containing increasing concen-
trations of Fe2 + (Fig. 8A). When the results were analysed
by Eadie–Hofstee plots (Fig. 8B), it was found that vali-
nomycin had very little effect on the Km values for Fe
2 +
transport but reduced the Vmax values (Fig. 9).
One possible effect of valinomycin, resulting from in-
creased membrane conductance of K+, is to change cell
volume which, in turn, could affect Fe2 + uptake. The relative
cell volume of reticulocytes was determined by measurement
of hemoglobin concentration and PCV of cell suspensions
and calculation of mean corpuscular hemoglobin concentra-
tion (MCHC) after incubation at 37 jC for 15 min in
mixtures of isotonic sucrose and KCl solutions with orFig. 8. (A) Effect of iron concentration on Fe2 + uptake by rabbit
reticulocytes incubated in KCl solution in the presence of varying
concentrations of valinomycin. The concentrations of valinomycin are
shown in B which is an Eadie–Hoffstee plot of the results shown in A. This
is a single experiment which was repeated twice more with similar results.
Fig. 11. Concentration-dependent inhibition of Fe2 + uptake by DES.
Reticulocytes were incubated in KCl solution containing 20 AM Fe2 + and
the indicated concentrations of DES. The results are shown as the
meansF S.E. of three experiments.
Fig. 9. Effect of valinomycin on the Michaelis–Menten constant (Km) and
maximum rate of Fe2 + uptake (Vmax) calculated from three experiments of
the type shown in Fig. 8. Each point is the meanF S.E.
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those of cells suspended in 0.155 M KCl before incubation
were then used to calculate the relative cell volume of the
incubated cells as a percentage. Valinomycin reduced the
relative cell volume of reticulocytes incubated in KCl con-
centrations from 0 to 100 mM but not at 140 mM (Fig. 10). It
also reduced the relative cell volume of reticulocytes incu-
bated in isotonic NaCl to 66.8F 1.2% (n = 5).
3.3. Action of DES on Fe2+ uptake
DES inhibited Fe2 + uptake in a dose-dependent manner,
near maximum inhibition occurring at 10 AM concentra-Fig. 10. Changes in relative cell volume of reticulocytes incubated for 15
min in isotonic solutions (pH 7.0) containing varying concentrations of KCl
in the absence (control) or presence of 0.5 AM valinomycin. The solutions
were prepared by mixing isotonic sucrose and KCl. The values (meansF
S.E. of three experiments) are expressed relative to freshly obtained cells
suspended in KCl and were calculated from the MCHC of the cells before
and after the incubations, as described in the text.tion (Fig. 11). Two related compounds, hexestrol and
dienestrol, had almost identical effects (results not shown).
When the effect of varying DES concentration on iron
uptake from KCl solution containing different concentra-
tions of Fe2 + was examined, it was found that DES had no
significant effect of Km for iron uptake but reduced the
Vmax values as the DES concentration was raised (results
not shown).
3.4. Effects of protein kinase inhibitors on Fe2+ uptake
Three protein kinase inhibitors were tested, stauro-
sporine, genistein and tyrphostin 25. They were all
strong inhibitors of Fe2 + uptake from KCl solution
(Table 1).Table 1
Inhibition of iron uptake by protein kinase inhibitors
Inhibitor Concentration (AM) Iron uptake (% control value)
Staurosporine 0.1 64F 7.6
0.3 42F 6.1
1.0 27F 5.0
2.0 22F 3.7
Genistein 10 100F 4.5
30 99F 7.2
100 40F 4.1
500 29F 6.1
Tyrphostin 25 25 33F 2.3
50 17F 3.2
100 11F 2.9
200 9F 1.7
The uptake of 20 AM Fe(II) by reticulocytes was measured using cells
incubated in isotonic KCl solution (pH 7.0) in the absence (control) or
presence of the inhibitors at the concentrations indicated. The results are
presented as the percentage of the values obtained in the control
incubations. Each value is the meanF S.E. of four experiments.
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These experiments were performed using fresh rabbit
erythroid cells without manipulation of their Mg2 + content,
unlike many previous investigations of Mg2 + transport.
They provide further evidence that low-affinity iron uptake
by the cells is mediated by a Mg2 +/Fe2 + exchange process,
probably by the Mg2 +/Na+ antiport, as discussed previously
[4,11]. In support of this conclusion, Mg2 + efflux from the
cells was found to be stimulated in a concentration-depen-
dent manner by addition of Fe2 + to the KCl incubation
solution or by replacement of KCl by NaCl. Moreover, the
molar ratio of Fe2 + uptake and iron-stimulated Mg2 + efflux
from reticulocytes into KCl solution did not differ signifi-
cantly from 1.0, indicating that there was a one-to-one
exchange of Mg2 + for Fe2 +.
Further support for the exchange process is derived from
the effects of inhibitors and the changes which occur during
maturation of reticulocytes. The potent inhibitors of low-
affinity iron uptake, valinomycin, DES, imipramine and
amiloride [3,4] all inhibited iron-stimulated Mg2 + efflux
into KCl solution to almost the same degree as they
inhibited Fe2 + uptake. However, imipramine and amiloride
had no significant effect on Mg2 + efflux into NaCl solution
at the concentrations used and valinomycin caused a large
increase. With respect to these results, Mg2 + efflux from rat
erythrocytes into a NaCl medium was previously shown to
be less sensitive than efflux into KCl to inhibition by
quinidine [19] which also inhibits Fe2 + uptake from KCl
solution [3,11]. A similarly lower sensitivity to inhibition by
DES, imipramine and amiloride may account for the results
obtained in the present study. The explanation of these
effects is unclear but they suggest that even if Fe2 + and
Na+ exchange for Mg2 + via the same antiport, as concluded
earlier [11], they probably interact with different compo-
nents of the antiport. The results obtained with valinomycin
are even more difficult to explain as will be discussed
below.
The rate of low-affinity Fe2 + transport into mature rabbit
[2,4,11] and rat [5] erythrocytes is lower than into reticulo-
cytes. In the present work, iron-stimulated Mg2 + efflux was
also shown to be lower in the mature cells. This was
associated with a lower Mg2 + content of the cells, the
values obtained being similar to those reported previously
[20,21] and are in accordance with the observation that red
cell magnesium concentration falls as the cells age [22].
Also, several other cation transport processes are more
active in reticulocytes than erythrocytes [23].
Valinomycin produced profound inhibition of Fe2 + up-
take and iron-stimulated Mg2 + efflux in KCl solution at
concentrations of 0.3–0.5 AM. It is possible that the
inhibition is due to a change in membrane potential because
the degree of inhibition increased with increasing KCl
concentration, in association with a rising Vm. However,
nonactin which, like valinomycin, is a K+ ionophore and
altered Vm in a similar manner to valinomycin, had no effecton Fe2 + uptake. Moreover, in 100 and 140 mM KCl, the Vm
was almost the same in the presence as in the absence of
valinomycin, yet the ionophore produced marked inhibition
of Fe2 + uptake. Hence, it is unlikely that the inhibitory
effect of valinomycin on Fe2 + uptake is due to alteration of
Vm. Fe
2 + uptake probably occurs by an electroneutral
process such as the one-to-one Mg2 +/Fe2 + exchange ob-
served in this study.
The observation that valinomycin at a concentration of
0.3 AM is inhibitory in KCl, RbCl or CsCl solutions but not
in LiCl and choline chloride solutions suggests that the
inhibition is due to greater membrane conductance of K+,
Rb+ and Cs+ compared with the other cations. Valinomycin
has greater selectivity for the first three ions [15–17].
However, inhibition was observed in KCl concentrations
varying from 25 to 140 mM and within this range, net
movement of K+ could be in either direction. At lower salt
concentrations, net loss of K+ from the cells could explain
the observed decreased in cell size but cell shrinkage did not
occur in 140 mM KCl even though inhibition of Fe2 +
uptake was still observed. Hence a valinomycin-induced
change in cell size cannot explain its inhibitory effect.
The most likely explanation for the inhibition produced
by valinomycin in KCl solution is that it is due to the action
of the ionophore–K+ complex rather than the free ionophore
on the iron transport mechanism. This would explain why
iron transport was inhibited by lower concentrations of
valinomycin when the cells were incubated in the presence
of K+, Rb+ or Cs+ than when incubated with Li+ or choline+,
and why the inhibition was greater when the salt concen-
tration was higher. Presumably, higher salt and valinomycin
concentrations would be required to achieve inhibitory
levels of the ionophore–metal complexes in the membrane
when Li+ or choline+ were used than with the other three
ions.
The exact mechanism by which the valinomycin–metal
complex inhibits Fe2 + transport is unknown. It was of non-
competitive nature as indicated by the change in Vmax but
not Km values for Fe
2 + uptake. Hence, the effect is likely to
be an indirect one rather than due to interaction with the
metal-binding sites of the transporter. Possibly it is due to an
effect on the conformation of the transporter or on cell
membrane properties which influences the function of the
transporter, or on a mechanism required for activation of the
carrier such as phosphorylation.
By contrast to its inhibition of iron-dependent Mg2 +
efflux into KCl solution, valinomycin markedly stimulated
Mg2 + efflux into NaCl. Three major differences are readily
apparent with respect to the two incubation media. One is
that the membrane potential (Vm) is much greater (inside
negative) in isotonic NaCl than KCl. This would be
expected to inhibit rather than enhance Mg2 + efflux. How-
ever, if the efflux occurs by an electroneutral process by
exchange with Na+, the change in Vm could possibly
activate the transporter, resulting in the observed enhance-
ment of Mg2 + efflux. The second difference is that valino-
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but not in isotonic KCl. The change in cell volume may
activate a transporter. The third difference is that valinomy-
cin has a high affinity for K+ but only extremely low affinity
for Na+. Reaction with K+ produces distinct conformational
changes [24] and a net positive charge on the valinomycin–
K+ complex. Either of these two effects may be required for
the inhibition found in KCl solutions. Uncomplexed vali-
nomycin is a neutral molecule which probably has greater
lipophilicity and solubility in cell membranes compared
with the K+ complex, and it also has a different confirmation
from the complex [24]. These properties may be responsible
for the effect observed in NaCl solution. In contrast to its
effect on Mg2 + efflux into NaCl solution, valinomycin did
not significantly affect Fe2 + uptake. This is probably
because Fe2 + uptake is markedly inhibited by Na+ due to
competition for the transport mechanism [5,11]. However,
valinomycin has been shown to markedly stimulate Na+
entry into rabbit erythrocytes [25]. This suggests that the
increased Mg2 + efflux observed in the present study was
due to exchange with extracellular Na+ by activation of the
antiport.
DES, like valinomycin, blocked Fe2 + uptake in a non-
competitive manner. DES is known to inhibit several ion-
motive ATPases [26–28] as are quercetin [26] and oligo-
mycin [29], both of which are also potent inhibitors of
low-affinity iron transport [3,4,11]. This suggests that the
transporter may depend on ATPase activity for its function.
Mg2 + efflux is markedly impaired in metabolically deplet-
ed human erythrocytes with low ATP levels [30,31], as is
Fe2 + uptake by rabbit cells [11]. However, whether the
hydrolysis of ATP is required to drive an active transport
process is unknown [32]. Phosphorylation of a 230-kDa
membrane protein is associated with increased Mg2 +
transport out of chicken red cells and both the phosphor-
ylation and Mg2 + transport are inhibited by amiloride [12].
The results presented here on the effects of protein kinase
inhibitors indicate that phosphorylation is also required for
low-affinity Fe2 + transport. Although no inhibitors are
absolutely specific for particular types of protein kinase,
genistein and tyrphostins are believed to show a high level
of specificity for tyrosine protein kinase [33,34] which
suggests that this kinase is involved. Staurosporine, a non-
specific protein kinase inhibitor, was previously shown to
block Mg2 +/Na+ exchange in rat erythrocytes [35].
The function of the low-affinity Fe2 + transport mecha-
nism is unclear. The process can transport other divalent
transition metals in addition to Fe2 + (Mn2 +, Co2 +, Zn2 +,
Ni2 +) [4]. Possibly its primary function is to transport one or
more of these metals rather than Fe2 +. However, this is
unlikely for at least three reasons. (1) The transport of all
these metals into erythroid cells is inhibited by extracellular
Na+ [4], the main cation of extracellular fluid. (2) The
transport process has a low affinity for all of the metals
[4] and for optimal function requires concentrations of the
metals much higher than those present in extracellular fluidin vivo. (3) The rate of iron uptake is far greater than that of
iron uptake from the physiological source, transferrin [3,5]
and hence greatly exceeds that required for hemoglobin
synthesis; moreover, low-affinity transport persists in ma-
ture erythrocytes which have little or no requirement for iron
uptake.
It is possible that the function of the low-affinity trans-
porter lies in the export of one or more transition metals to
help maintain cellular homeostasis or for transport across
cellular barriers in the body. There is evidence that Mg2 +
transport can reverse its direction, leading to Mg2 + uptake
and Na+ efflux [35]. Mn2 + can replace Na+ in the exchange
process and be transported in exchange for Mg2 + in both
directions across rat erythrocyte cell membranes [19]. Also,
Mn2 + efflux from rabbit erythroid cells is stimulated by
extracellular Fe2 + as well as by Mn2 +, Mg2 + and Na+ [36].
Hence, the physiological role of the transporter may be to
export one or more of these metals. Iron export is not an
important function in erythroid cells but it is important in
other types of cells, for example, intestinal mucosal cells,
hepatocytes, macrophages and placental trophoblast cells.
One cellular iron exporter has been identified and called
IREG1 [37], ferroportin1 [38] and MTP1 [39]. However, its
mechanism of function and whether it is the only iron
exporter is unknown. Also, Na+-dependent Mg2 + efflux
has been described in many cell types as well as erythroid
cells [40]. Hence, the possibility remains that efflux of Fe2 +
or other transition metals is mediated by this transporter.
With respect to iron, dietary deficiency of Mg2 + in rats has
been found to lead to elevated plasma and hepatic iron
levels [41], suggesting that interaction between iron and
magnesium in the absorptive process and enhanced iron
absorption had occurred.Acknowledgements
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